查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1734796

2032 年非处方药市场预测：按产品、剂型、类别、分销管道、最终用户和地区进行的全球分析

Over the Counter Drugs Market Forecasts to 2032 - Global Analysis By Product, Dosage Form, Category, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球非处方药市场预计在 2025 年达到 566.1 亿美元，到 2032 年将达到 859.6 亿美元，预测期内的复合年增长率为 8%。

消费者无需处方笺即可购买非处方药（OTC）。头痛、感冒、过敏和消化系统疾病等常见疾病均可透过非处方药物治疗。非处方药受到 FDA 等监管机构的监管，按照处方笺服用时无需处方笺即可被视为安全有效。它们通常在药局、超级市场和便利商店出售。标籤上包含有关使用、剂量和警告的重要细节。

自我治疗的偏好日益增加

人们普遍意识到非处方药的可用性，导致对非处方治疗的需求增加。当人们选择非处方药来节省时间和金钱时，可用性和便利性是重要的考虑因素。越来越多的顾客正在寻找经济有效的治疗方法过敏、不适和感冒等常见疾病。由于持续的健康和保健锻炼，寻求预防措施的人们更倾向于非处方药。因此，由于顾客的信任以及从网路上或直接从药局购买药品的便利性，非处方药产业持续成长。

滥用和副作用的可能性

由于资讯不足而导致的不当使用可能会影响消费者的健康。有关这些药物安全性的法规日益严格，往往会限制其供应。有关滥用和副作用的负面宣传已经削弱了消费者对一些非处方药的信心。由于谨慎的消费者寻求更安全的替代品和处方笺治疗方法，市场成长将受到限制。

产品创新与个性化

注重健康且追求便利的消费者被能够提供更快起效、更有效的药物配方所吸引。客製化的非处方药，例如针对特定症状的配方和有针对性的维生素，可以提高客户满意度。此外，数位健康平台的成长使客户能够自订自己的选择，从而推动了对个人化产品的需求。为了满足消费者对整体健康解决方案的需求，製造商正在转向天然和有机产品。因此，这些发展正在增加市场潜力、吸引新客户并加强品牌忠诚度。

市场竞争激烈

结果，製造商被迫选择削减成本而不是创新。当有许多企业销售类似产品时，吸引顾客可能会很困难。因此，公司很难实现产品差异化。此外，激烈的竞争往往会导致激进的行销，做出虚假宣传或提供没有证据支持的利益。此类行为可能会对消费者信任和品牌声誉造成长期损害。

COVID-19的影响

COVID-19 疫情对一般成药)市场产生了重大影响。最初，恐慌性购买和囤积导致对免疫增强剂、止痛药以及感冒和流感药物的需求激增。但由于零售药局客流量减少和生产延迟，供应链中断。消费者健康和卫生意识的增强推动了某些类别商品的成长，尤其是维生素和补充剂。随着消费者转向网上购买，电子商务平台获得了发展动力，再形成了市场分销管道和消费行为。

睡眠补充剂市场预计将成为预测期内最大的市场

由于人们对睡眠障碍的认识不断提高，预计睡眠补充剂领域将在预测期内占据最大的市场占有率。随着越来越多的人面临失眠等症状，对易于取得的非处方笺药的需求也越来越大。非处方助眠药物，如褪黑激素和抗组织胺药物，为处方药提供了便捷的替代品。消费者对价格实惠且易于获得的治疗方法的偏好正在推动市场成长。此外，人们对自我护理和健康的兴趣日益浓厚，也促进了非处方药市场中睡眠辅助药物领域的扩张。

预计儿科领域在预测期内的复合年增长率最高。

由于儿童感冒、咳嗽和发烧等常见疾病的流行，预计预测期内儿科领域将出现最高的成长率。越来越多的父母开始选择非处方药 (OTC)，这些药物起效快，而且无需处方笺即可轻鬆取得。人们对儿科保健的认识不断提高，以及糖浆和咀嚼片等儿童友善配方的出现进一步推动了需求。製造商也致力于开发具有吸引人的口味和包装的安全、适合年龄的非处方药产品。儿科药品需求的增加对整个非处方药市场的成长做出了巨大贡献。

占比最大的地区：

由于中等收入群体的增加、都市化以及医疗保健支出的增加，预计亚太地区将在预测期内占据最大的市场占有率。中国、印度和日本等国家对维生素、草药和消化助剂的需求日益增长。健康素养的提高和对自我护理的偏见的减少正在重塑消费行为。与北美不同，传统药物在该地区的非处方药领域中发挥着重要作用。法规环境各不相同，影响产品的可用性。电子商务和本地药品製造的兴起也促进了区域药品的可及性，使非处方药成为广大民众的便捷选择。

复合年增长率最高的地区：

在预测期内，由于医疗保健意识高、医疗服务便捷以及法规结构强大，预计北美将呈现最高的复合年增长率。消费者越来越倾向于自我治疗小病，这导致对止痛药、感冒和流感药物以及胃肠药的需求增加。美国占据主导地位，这得益于零售药局和数位健康平台的扩张。严格的标籤和安全标准增强了消费者信心。此外，人口老化和文明病等人口变化也进一步增强了市场。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究资讯来源
    • 初级研究资讯来源
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章 全球非处方药市场（按产品）

  • 咳嗽、感冒和流感产品
  • 止痛药
  • 皮肤科产品
  • 胃肠药
  • 维生素和营养补充剂
  • 助眠剂
  • 减重产品
  • 戒烟辅助剂
  • 口腔护理产品
  • 眼科产品
  • 缓解过敏
  • 防腐剂和抗菌剂
  • 其他产品

第六章全球非处方药市场（按剂型）

  • 药片
  • 胶囊
  • 粉末
  • 软膏
  • 奶油
  • 液体和糖浆
  • 降低
  • 喷
  • 凝胶
  • 其他剂型

第七章全球非处方药市场（依类别）

  • 品牌非处方药
  • 学名药

8. 全球非处方药市场（依分销管道）

  • 零售药局
  • 医院药房
  • 网路药局
  • 便利商店
  • 超级市场
  • 其他分销管道

9. 全球非处方药市场（依最终用户）

  • 成人
  • 孩子
  • 老年人
  • 其他最终用户

第十章全球非处方药市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Johnson & Johnson
  • Pfizer
  • Bayer AG
  • Sanofi
  • GlaxoSmithKline（GSK）
  • Novartis AG
  • Reckitt Benckiser Group plc
  • Takeda Pharmaceutical Company Ltd.
  • Haleon
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Mylan
  • Boehringer Ingelheim International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Alkem Laboratories Ltd.
  • Piramal Enterprises
Product Code: SMRC29433

According to Stratistics MRC, the Global Over the Counter Drugs Market is accounted for $56.61 billion in 2025 and is expected to reach $85.96 billion by 2032 growing at a CAGR of 8% during the forecast period. Consumers can purchase over-the-counter (OTC) pharmaceuticals without a prescription. Common medical conditions like headaches, colds, allergies, and digestive disorders are treated with them. OTC medications are governed by regulatory bodies such as the FDA and, when taken as prescribed, are deemed safe and effective for use without a prescription. Usually, pharmacies, supermarkets, and convenience stores sell them. Important details on dosage, usage, and warnings are provided by labels.

Market Dynamics:

Driver:

Growing preference for self-medication

Demand for over-the-counter treatments has increased as a result of greater awareness of OTC drug availability. Accessibility and convenience are important considerations, since individuals choose over-the-counter medications to save time and money. More and more customers are looking for economical, efficient remedies for common ailments including allergies, discomfort, and colds. OTC medications have become more well-liked among people seeking preventative measures as a result of the continuous wellness and health movement. As a result, the OTC industry keeps growing because to customer confidence and the convenience of buying drugs online or straight from pharmacies.

Restraint:

Potential for misuse and side effects

The health of the consumer may be impacted by improper use brought on by insufficient instructions. Stricter regulations pertaining to these medications' safety frequently result in their availability being restricted. Consumer confidence in some over-the-counter products is eroded by negative publicity regarding abuse and negative side effects. As cautious consumers look for safer alternatives or prescription-based therapies, this in turn limits market growth.

Opportunity:

Product innovation and personalization

A convenience-seeking, health-conscious population is drawn to formulation advancements that provide faster-acting, more effective medicines. Customer satisfaction is increased with customised over-the-counter remedies, such as condition-specific formulations or targeted vitamins. Furthermore, customers can now customise their options thanks to the growth of digital health platforms, which increases demand for personalised goods. As a response to consumer demand for holistic health solutions, manufacturers are also including natural and organic products. These developments are therefore increasing market potential, drawing in new customers, and strengthening brand loyalty.

Threat:

Intense market competition

Manufacturers are compelled to choose cost reduction above innovation as a result. When there are numerous companies selling comparable goods, it becomes challenging to win over customers. Consequently, businesses could find it difficult to set themselves apart with their products. Furthermore, fierce rivalry frequently leads to aggressive marketing that makes false claims or offers benefits that aren't supported by evidence. Such actions have the potential to undermine consumer trust and brand reputation over time.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the Over the Counter (OTC) drugs market. Initially, panic buying and stockpiling led to a surge in demand for immunity boosters, pain relievers, and cold and flu medications. However, reduced footfall in retail pharmacies and delayed manufacturing disrupted supply chains. Increased consumer awareness of health and hygiene sustained growth in some segments, particularly vitamins and supplements. E-commerce platforms gained traction as consumers shifted toward online purchasing, reshaping the market's distribution channels and consumer behaviour.

The sleep aids segment is expected to be the largest during the forecast period

The sleep aids segment is expected to account for the largest market share during the forecast period, due to increasing awareness of sleep disorders. As more people face conditions like insomnia, the demand for accessible, non-prescription solutions has risen. OTC sleep aids, such as melatonin and antihistamines, provide a convenient alternative to prescription medications. Consumer preference for affordable and easily accessible treatments boosts market growth. Additionally, the growing trend of self-care and wellness contributes to the expansion of the sleep aids segment within the OTC market.

The children segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the children segment is predicted to witness the highest growth rate, due to the rising prevalence of common illnesses like colds, coughs, and fevers among children. Parents increasingly prefer OTC medications for quick relief and ease of access without a prescription. Growing awareness about pediatric healthcare and availability of child-friendly formulations such as syrups and chewables further fuel demand. Manufacturers are also focusing on developing safe, age-specific OTC products with appealing flavors and packaging. This heightened demand from the children segment contributes notably to the overall growth of the OTC drugs market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising middle-class incomes, urbanization, and increased healthcare expenditure. Countries like China, India, and Japan are experiencing heightened demand for vitamins, herbal remedies, and digestive aids. Growing health literacy and reduced stigma around self-care practices are reshaping consumer behavior. Unlike North America, traditional medicines play a significant role in this region's OTC segment. Regulatory environments vary widely, influencing product availability. E-commerce penetration and local pharmaceutical manufacturing are also boosting regional access, making OTC drugs a convenient option for a broad population base.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR by high healthcare awareness, easy accessibility, and strong regulatory frameworks. Consumers increasingly prefer self-medication for minor ailments, contributing to growing demand for analgesics, cold and flu medications, and gastrointestinal products. The U.S. holds a dominant share, fueled by retail pharmacy expansion and digital health platforms. Stringent labeling and safety standards enhance consumer trust. Additionally, demographic shifts, such as aging populations and lifestyle-related disorders, further bolster the market.

Key players in the market

Some of the key players profiled in the Over the Counter Drugs Market include Johnson & Johnson, Pfizer, Bayer AG, Sanofi, GlaxoSmithKline (GSK), Novartis AG, Reckitt Benckiser Group plc, Takeda Pharmaceutical Company Ltd., Haleon, Teva Pharmaceutical Industries Ltd., Perrigo Company plc, Mylan, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., Alkem Laboratories Ltd. and Piramal Enterprises.

Key Developments:

In January 2025, Johnson & Johnson announced the acquisition of Intra-Cellular Therapies for $14.6 billion. This acquisition includes Caplyta (lumateperone), an oral therapy approved for treating schizophrenia and bipolar disorder depressive episodes.

In May 2024, Bayer Pharmaceuticals Private Limited acquired the remaining 25% stake in Bayer Zydus Pharma Pvt Ltd from Zydus Lifesciences Ltd, securing full ownership of the joint venture established in 2011. This move aimed to strengthen Bayer's position in the Indian pharmaceutical market by combining Zydus's local marketing expertise with Bayer's global innovation capabilities.

Products Covered:

  • Cough, Cold, and Flu Products
  • Analgesics
  • Dermatological Products
  • Gastrointestinal Products
  • Vitamins and Dietary Supplements
  • Sleep Aids
  • Weight Loss Products
  • Smoking Cessation Aids
  • Oral Care Products
  • Ophthalmic Products
  • Allergy Relief Medications
  • Antiseptics and Antibacterials
  • Other Products

Dosage Forms Covered:

  • Tablets
  • Capsules
  • Powders
  • Ointments
  • Creams
  • Liquids and Syrups
  • Drops
  • Sprays
  • Gels
  • Other Dosage Forms

Categories Covered:

  • Branded OTC Drugs
  • Generic OTC Drugs

Distribution Channels Covered:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Convenience Stores
  • Supermarkets
  • Other Distribution Channels

End Users Covered:

  • Adults
  • Children
  • Geriatric Population
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Over the Counter Drugs Market, By Product

  • 5.1 Introduction
  • 5.2 Cough, Cold, and Flu Products
  • 5.3 Analgesics
  • 5.4 Dermatological Products
  • 5.5 Gastrointestinal Products
  • 5.6 Vitamins and Dietary Supplements
  • 5.7 Sleep Aids
  • 5.8 Weight Loss Products
  • 5.9 Smoking Cessation Aids
  • 5.10 Oral Care Products
  • 5.11 Ophthalmic Products
  • 5.12 Allergy Relief Medications
  • 5.13 Antiseptics and Antibacterials
  • 5.14 Other Products

6 Global Over the Counter Drugs Market, By Dosage Form

  • 6.1 Introduction
  • 6.2 Tablets
  • 6.3 Capsules
  • 6.4 Powders
  • 6.5 Ointments
  • 6.6 Creams
  • 6.7 Liquids and Syrups
  • 6.8 Drops
  • 6.9 Sprays
  • 6.10 Gels
  • 6.11 Other Dosage Forms

7 Global Over the Counter Drugs Market, By Category

  • 7.1 Introduction
  • 7.2 Branded OTC Drugs
  • 7.3 Generic OTC Drugs

8 Global Over the Counter Drugs Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Retail Pharmacies
  • 8.3 Hospital Pharmacies
  • 8.4 Online Pharmacies
  • 8.5 Convenience Stores
  • 8.6 Supermarkets
  • 8.7 Other Distribution Channels

9 Global Over the Counter Drugs Market, By End User

  • 9.1 Introduction
  • 9.2 Adults
  • 9.3 Children
  • 9.4 Geriatric Population
  • 9.5 Other End Users

10 Global Over the Counter Drugs Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Pfizer
  • 12.3 Bayer AG
  • 12.4 Sanofi
  • 12.5 GlaxoSmithKline (GSK)
  • 12.6 Novartis AG
  • 12.7 Reckitt Benckiser Group plc
  • 12.8 Takeda Pharmaceutical Company Ltd.
  • 12.9 Haleon
  • 12.10 Teva Pharmaceutical Industries Ltd.
  • 12.11 Perrigo Company plc
  • 12.12 Mylan
  • 12.13 Boehringer Ingelheim International GmbH
  • 12.14 Sun Pharmaceutical Industries Ltd.
  • 12.15 Cipla Inc.
  • 12.16 Dr. Reddy's Laboratories Ltd.
  • 12.17 Alkem Laboratories Ltd.
  • 12.18 Piramal Enterprises

List of Tables

  • Table 1 Global Over the Counter Drugs Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Over the Counter Drugs Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Over the Counter Drugs Market Outlook, By Cough, Cold, and Flu Products (2024-2032) ($MN)
  • Table 4 Global Over the Counter Drugs Market Outlook, By Analgesics (2024-2032) ($MN)
  • Table 5 Global Over the Counter Drugs Market Outlook, By Dermatological Products (2024-2032) ($MN)
  • Table 6 Global Over the Counter Drugs Market Outlook, By Gastrointestinal Products (2024-2032) ($MN)
  • Table 7 Global Over the Counter Drugs Market Outlook, By Vitamins and Dietary Supplements (2024-2032) ($MN)
  • Table 8 Global Over the Counter Drugs Market Outlook, By Sleep Aids (2024-2032) ($MN)
  • Table 9 Global Over the Counter Drugs Market Outlook, By Weight Loss Products (2024-2032) ($MN)
  • Table 10 Global Over the Counter Drugs Market Outlook, By Smoking Cessation Aids (2024-2032) ($MN)
  • Table 11 Global Over the Counter Drugs Market Outlook, By Oral Care Products (2024-2032) ($MN)
  • Table 12 Global Over the Counter Drugs Market Outlook, By Ophthalmic Products (2024-2032) ($MN)
  • Table 13 Global Over the Counter Drugs Market Outlook, By Allergy Relief Medications (2024-2032) ($MN)
  • Table 14 Global Over the Counter Drugs Market Outlook, By Antiseptics and Antibacterials (2024-2032) ($MN)
  • Table 15 Global Over the Counter Drugs Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 16 Global Over the Counter Drugs Market Outlook, By Dosage Form (2024-2032) ($MN)
  • Table 17 Global Over the Counter Drugs Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 18 Global Over the Counter Drugs Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 19 Global Over the Counter Drugs Market Outlook, By Powders (2024-2032) ($MN)
  • Table 20 Global Over the Counter Drugs Market Outlook, By Ointments (2024-2032) ($MN)
  • Table 21 Global Over the Counter Drugs Market Outlook, By Creams (2024-2032) ($MN)
  • Table 22 Global Over the Counter Drugs Market Outlook, By Liquids and Syrups (2024-2032) ($MN)
  • Table 23 Global Over the Counter Drugs Market Outlook, By Drops (2024-2032) ($MN)
  • Table 24 Global Over the Counter Drugs Market Outlook, By Sprays (2024-2032) ($MN)
  • Table 25 Global Over the Counter Drugs Market Outlook, By Gels (2024-2032) ($MN)
  • Table 26 Global Over the Counter Drugs Market Outlook, By Other Dosage Forms (2024-2032) ($MN)
  • Table 27 Global Over the Counter Drugs Market Outlook, By Category (2024-2032) ($MN)
  • Table 28 Global Over the Counter Drugs Market Outlook, By Branded OTC Drugs (2024-2032) ($MN)
  • Table 29 Global Over the Counter Drugs Market Outlook, By Generic OTC Drugs (2024-2032) ($MN)
  • Table 30 Global Over the Counter Drugs Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 31 Global Over the Counter Drugs Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 32 Global Over the Counter Drugs Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 33 Global Over the Counter Drugs Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 34 Global Over the Counter Drugs Market Outlook, By Convenience Stores (2024-2032) ($MN)
  • Table 35 Global Over the Counter Drugs Market Outlook, By Supermarkets (2024-2032) ($MN)
  • Table 36 Global Over the Counter Drugs Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 37 Global Over the Counter Drugs Market Outlook, By End User (2024-2032) ($MN)
  • Table 38 Global Over the Counter Drugs Market Outlook, By Adults (2024-2032) ($MN)
  • Table 39 Global Over the Counter Drugs Market Outlook, By Children (2024-2032) ($MN)
  • Table 40 Global Over the Counter Drugs Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 41 Global Over the Counter Drugs Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.